These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12801602)

  • 1. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.
    Barter P; Kastelein J; Nunn A; Hobbs R;
    Atherosclerosis; 2003 Jun; 168(2):195-211. PubMed ID: 12801602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL: a recipe for longevity.
    Barter P
    Atheroscler Suppl; 2004 May; 5(2):25-31. PubMed ID: 15121032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein cholesterol-raising strategies.
    Kuvin JT; Alsheikh-Ali AA; Karas RH
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):196-204. PubMed ID: 16495756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoproteins and coronary heart disease.
    Barter PJ; Rye KA
    Atherosclerosis; 1996 Mar; 121(1):1-12. PubMed ID: 8678914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.
    Hersberger M; von Eckardstein A
    Drugs; 2003; 63(18):1907-45. PubMed ID: 12930163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
    Chapman MJ
    Pharmacol Ther; 2006 Sep; 111(3):893-908. PubMed ID: 16574234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the prevention of atherosclerosis in patients with low high-density lipoprotein cholesterol.
    Brousseau ME; Schaefer EJ
    Curr Atheroscler Rep; 2001 Sep; 3(5):365-72. PubMed ID: 11487447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL cholesterol and protective factors in atherosclerosis.
    Assmann G; Gotto AM
    Circulation; 2004 Jun; 109(23 Suppl 1):III8-14. PubMed ID: 15198960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting high-density lipoproteins.
    Gordon DJ
    Endocrinol Metab Clin North Am; 1998 Sep; 27(3):699-709, xi. PubMed ID: 9785061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.
    Estrada-Luna D; Ortiz-Rodriguez MA; Medina-Briseño L; Carreón-Torres E; Izquierdo-Vega JA; Sharma A; Cancino-Díaz JC; Pérez-Méndez O; Belefant-Miller H; Betanzos-Cabrera G
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30360466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.
    Sacks FM;
    Am J Cardiol; 2002 Jul; 90(2):139-43. PubMed ID: 12106843
    [No Abstract]   [Full Text] [Related]  

  • 15. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy.
    Boden WE; Pearson TA
    Am J Cardiol; 2000 Mar; 85(5):645-50, A10. PubMed ID: 11078282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of coronary heart disease: the role of high density lipoproteins.
    Miller NE
    Postgrad Med J; 1980 Aug; 56(658):575-8. PubMed ID: 7465461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting high-density lipoproteins: update on a promising therapy.
    Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
    Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.